Your browser is no longer supported. Please, upgrade your browser.
Settings
ZGNX Zogenix, Inc. daily Stock Chart
ZGNX [NASD]
Zogenix, Inc.
Index- P/E- EPS (ttm)-2.87 Insider Own0.20% Shs Outstand43.01M Perf Week4.84%
Market Cap1.85B Forward P/E- EPS next Y-3.83 Insider Trans- Shs Float40.69M Perf Month-1.80%
Income-105.00M PEG- EPS next Q-1.04 Inst Own- Short Float16.72% Perf Quarter-9.59%
Sales0.00M P/S- EPS this Y-18.90% Inst Trans22.74% Short Ratio12.38 Perf Half Y1.60%
Book/sh13.73 P/B3.14 EPS next Y-0.80% ROA-30.30% Target Price70.90 Perf Year19.01%
Cash/sh12.53 P/C3.44 EPS next 5Y2.80% ROE-40.50% 52W Range33.42 - 62.75 Perf YTD7.57%
Dividend- P/FCF- EPS past 5Y6.90% ROI-29.40% 52W High-31.35% Beta1.79
Dividend %- Quick Ratio- Sales past 5Y-26.00% Gross Margin- 52W Low28.91% ATR2.02
Employees68 Current Ratio9.90 Sales Q/Q- Oper. Margin- RSI (14)56.95 Volatility5.04% 4.78%
OptionableYes Debt/Eq0.00 EPS Q/Q35.80% Profit Margin- Rel Volume1.65 Prev Close42.55
ShortableYes LT Debt/Eq0.00 EarningsNov 08 AMC Payout- Avg Volume549.72K Price43.08
Recom1.50 SMA204.07% SMA502.55% SMA200-3.33% Volume906,586 Change1.25%
Nov-05-18Initiated Piper Jaffray Overweight
Sep-14-18Initiated BofA/Merrill Buy $63
Sep-12-18Initiated Northland Capital Outperform $70
Sep-07-18Initiated B. Riley FBR Buy $116
Aug-23-18Initiated Ladenburg Thalmann Buy $71
Aug-15-18Resumed Stifel Buy $65 → $69
Jul-13-18Reiterated Stifel Buy $55 → $65
Nov-27-17Initiated JMP Securities Mkt Outperform
Oct-03-17Reiterated Mizuho Buy $28 → $51
Sep-29-17Upgrade William Blair Mkt Perform → Outperform
Oct-04-16Resumed Leerink Partners Outperform $17
Aug-11-15Reiterated Oppenheimer Outperform $20 → $23
Jul-15-15Reiterated Brean Capital Buy $20 → $28
Apr-22-15Initiated Piper Jaffray Overweight $2.50
Dec-29-14Initiated Brean Capital Buy $2.50
Jun-06-14Initiated R. F. Lafferty Buy $3.50
Oct-29-13Upgrade Stifel Hold → Buy $5
Jun-21-13Resumed Oppenheimer Perform
Mar-05-13Initiated Brinson Patrick Market Outperform
Dec-10-12Downgrade Stifel Nicolaus Buy → Hold
Dec-09-18 12:28PM  Here is What Hedge Funds Think About Zogenix, Inc. (ZGNX) Insider Monkey
Dec-06-18 01:56PM  Final trades: Home Depot, Target, Charter Communications,... CNBC Videos
Dec-04-18 07:24AM  What Kind Of Share Price Volatility Should You Expect For Zogenix Inc (NASDAQ:ZGNX)? Simply Wall St.
Dec-03-18 04:05PM  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire +5.45%
09:00AM  Zogenix Announces Positive Phase 3 Trial Results on the Efficacy and Safety of FINTEPLA® (ZX008) in Dravet Syndrome GlobeNewswire
Dec-02-18 09:00AM  Zogenix Presents Positive Findings on the Impact of Treatment with FINTEPLA® (ZX008) on Everyday Executive Function in Patients with Dravet Syndrome GlobeNewswire
Nov-29-18 08:00AM  Zogenix to Host Investor Update Lunch on FINTEPLA® at the American Epilepsy Society 2018 Annual Meeting GlobeNewswire
Nov-27-18 11:15AM  Cannabis-Based Drug (Still) Helps Epilepsy, but How Safe Is It? Motley Fool
08:00AM  Zogenix to Participate in the Global Mizuho Investor Conference 2018 GlobeNewswire
Nov-26-18 08:00AM  Zogenix to Announce New Data at 72nd American Epilepsy Society Annual Meeting GlobeNewswire
Nov-15-18 08:55AM  Investor Expectations to Drive Momentum within Berkshire Hathaway, Zogenix, ICC, CIRCOR International, Principia Biopharma, and Technical Communications Discovering Underlying Factors of Influence GlobeNewswire
Nov-09-18 01:17AM  Edited Transcript of ZGNX earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents -5.89%
Nov-08-18 05:25PM  Zogenix: 3Q Earnings Snapshot Associated Press
04:01PM  Zogenix Provides Corporate Update and Reports Third Quarter Financial Results GlobeNewswire
Nov-07-18 08:00AM  Zogenix to Present at Stifel 2018 Healthcare Conference GlobeNewswire
Nov-04-18 09:36AM  The First Cannabis-Derived Drug Is Now on Pharmacy Shelves Motley Fool
Nov-01-18 08:00AM  Zogenix to Release Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 8 GlobeNewswire +5.87%
Oct-19-18 03:43PM  Zogenix Inc (NASDAQ:ZGNX): Is Breakeven Near? Simply Wall St.
Oct-18-18 08:22AM  Zogenix Sees Hammer Chart Pattern: Time to Buy? Zacks
Oct-15-18 05:06PM  Health Care Digest: Big IPO seeks big space, East Bay genomics company hires CFO, biotech award winners American City Business Journals
Oct-01-18 05:07PM  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire -5.77%
Sep-27-18 08:31PM  Is This the Biggest Threat to GW Pharmaceuticals' Marijuana Drug? Motley Fool
Sep-25-18 08:00AM  Zogenix to Present at LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology GlobeNewswire
Sep-21-18 07:30AM  Is Pot Stock GW Pharmaceuticals Undervalued? Motley Fool
Sep-14-18 09:37AM  Zogenix Has $3.4B Opportunity With Pediatric Epilepsy Asset, BofA Says In Bullish Initiation Benzinga
Sep-13-18 09:21AM  Investors in This Top Marijuana Stock Can't Overlook These 2 Serious Challenges Motley Fool
Sep-10-18 02:17PM  Six Biotechnology Names on My Watch List TheStreet.com
12:28PM  Here's Why Zogenix Slipped 14.9% in August Motley Fool
Sep-08-18 10:00AM  Don't Dread a Market Correction, Think Opportunistically Instead TheStreet.com
Sep-04-18 04:38PM  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
08:00AM  Zogenix Phase 2 Study Results Published in Epilepsia Show ZX008 Provides Durable Reduction in Seizure Frequency in Patients With Lennox-Gastaut Syndrome GlobeNewswire
08:00AM  Today's Research Reports on Trending Tickers: CRISPR Therapeutics and Zogenix ACCESSWIRE
Aug-30-18 08:00AM  Zogenix Announces New Data on Psychological and Socioeconomic Impact of Dravet Syndrome and Other Epileptic Encephalopathies at 13th European Congress on Epileptology GlobeNewswire
Aug-17-18 08:00AM  Today's Research Reports on Trending Tickers: Mallinckrodt Public and Zogenix ACCESSWIRE
Aug-16-18 09:40PM  Edited Transcript of ZGNX earnings conference call or presentation 6-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-07-18 06:21PM  Zogenix Prices Public Offering of Common Stock GlobeNewswire -6.76%
Aug-06-18 06:51PM  Zogenix: 2Q Earnings Snapshot Associated Press
05:14PM  Zogenix Announces Proposed Public Offering of 6,000,000 Shares of Common Stock GlobeNewswire
04:26PM  Zogenix Provides Corporate Update and Reports Second Quarter Financial Results GlobeNewswire
02:30PM  Zogenix, Inc. to Host Earnings Call ACCESSWIRE
Aug-01-18 04:29PM  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
08:00AM  Zogenix to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 6 GlobeNewswire
Jul-20-18 11:18AM  Tilrays IPO is creating a buzz, but dont overspend on marijuana stocks MarketWatch
08:21AM  3 Very Popular Marijuana Stocks on My "Do Not Buy" List Motley Fool
Jul-19-18 04:10PM  Is Marijuana the Best Medicine for Epilepsy? Motley Fool
03:26PM  These Epilepsy Drugmakers Are About to Brawl Motley Fool
Jul-18-18 09:21AM  3 Big-Name Marijuana Stocks With Plunging Profit Projections Motley Fool
07:30AM  The Market That Took BEAT Higher By 800% Could Do The Same For This Strong New Competitor ACCESSWIRE
Jul-17-18 07:30AM  Free Pre-Market Technical Recap on TherapeuticsMD and Three Additional Healthcare Stocks ACCESSWIRE
Jul-16-18 08:49AM  Zogenix (ZGNX) in Focus: Stock Moves 9.8% Higher Zacks
08:00AM  Today's Research Reports on Trending Tickers: Zogenix and Momenta Pharmaceuticals ACCESSWIRE
Jul-14-18 02:02PM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Jul-13-18 05:34PM  Why Zogenix Inc. Shares Jumped 10% on Friday Motley Fool +9.75%
08:54AM  Zogenix's Epilepsy Candidate Successful in Phase III Study Zacks
08:34AM  Benzinga's Daily Biotech Pulse: Amgen Resubmits Osteoporosis Drug BLA, Auris Medical Prices Offering Benzinga
08:00AM  Today's Research Reports on Stocks to Watch: Galmed Pharmaceuticals and Zogenix ACCESSWIRE
Jul-12-18 05:15PM  Why Twitter, Papa John's International, and Zogenix Jumped Today Motley Fool +20.73%
12:57PM  Zogenix (ZGNX) Stock Soars on Anti-Seizure Drug Results InvestorPlace
11:51AM  Why Zogenix Inc. Is Soaring Today Motley Fool
10:10AM  Zogenix's seizure drug clears late-stage trial, shares soar Reuters
07:20AM  Zogenix shares soar 19% premarket after news of positive trial for severe epilepsy treatment MarketWatch
07:09AM  Zogenix's treatment for rare epilepsy meets advanced study goal Reuters
07:00AM  Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome GlobeNewswire
Jul-03-18 09:31AM  3 Biotech Stocks With Major Catalysts Incoming Motley Fool
Jul-02-18 04:32PM  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
08:00AM  Zogenix Welcomes New Global Chief Commercial Officer GlobeNewswire
Jun-27-18 12:25PM  Heres the Reason that GWPH Stock Tumbled Despite Regulatory Victory InvestorPlace
Jun-19-18 08:46AM  Are Options Traders Betting on a Big Move in Zogenix (ZGNX) Stock? Zacks
Jun-07-18 07:50AM  Free Daily Technical Summary Reports on Endo International and Three Other Healthcare Stocks ACCESSWIRE
Jun-01-18 04:24PM  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
May-20-18 01:11PM  This Cannabis-Based Drug Is On the Verge of Making History Motley Fool
May-15-18 09:41AM  Edited Transcript of ZGNX earnings conference call or presentation 9-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-14-18 08:21AM  Despite Losing $88 Million in Q2, This Pot Stock Still Has More Cash Than Any of Its Peers Motley Fool
08:00AM  Zogenix to Participate in the Bank of America Merrill Lynch 2018 Healthcare Conference GlobeNewswire
May-09-18 04:47PM  Zogenix: 1Q Earnings Snapshot Associated Press
04:01PM  Zogenix Provides Corporate Update and Reports First Quarter Financial Results GlobeNewswire
May-04-18 08:21AM  A Major Marijuana Milestone Is Less Than 2 Months Away Motley Fool
08:00AM  Zogenix to Release First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9 GlobeNewswire
May-01-18 05:00PM  Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Apr-27-18 08:00AM  Zogenix Announces Initial Quality of Life and Cognitive Function Data From Phase 3 Trial of ZX008 in Dravet Syndrome GlobeNewswire
Apr-25-18 08:00AM  Zogenix Announces Presentation of New Efficacy and Safety Data from its First Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome GlobeNewswire
08:00AM  Report: Exploring Fundamental Drivers Behind Urban Edge Properties, FLIR, Zogenix, Watts Water Technologies, CDW, and BMC Stock New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Apr-11-18 08:00AM  Zogenix to Participate in LEERINK Partners CNS Day GlobeNewswire
Apr-04-18 07:30AM  Here's Why The Mayo Clinic Owns 10% of This Unknown Epilepsy Stock with Big Upcoming FDA Catalyst ACCESSWIRE
Mar-28-18 07:20AM  Wired News Shire Collaborates with NanoMedSyn to Treat Potential Lysosomal Storage Disorder ACCESSWIRE
Mar-20-18 06:34AM  Why Didn't Investors Care About This Marijuana Stock's Big News? Motley Fool
Mar-09-18 09:31AM  Employee Stock Options Liability Significant For Zogenix Forbes
Mar-08-18 12:11AM  Edited Transcript of ZGNX earnings conference call or presentation 6-Mar-18 9:30pm GMT Thomson Reuters StreetEvents
Mar-07-18 05:03AM  Zogenix reports 4Q loss Associated Press
Mar-06-18 04:01PM  Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results GlobeNewswire
03:00PM  Why Zogenix Inc. Shares Shot Up 16.6% in February Motley Fool
12:30PM  Zogenix, Inc. to Host Earnings Call ACCESSWIRE
Mar-05-18 08:50AM  Why Earnings Season Could Be Great for Zogenix (ZGNX) Zacks
Mar-01-18 08:25AM  Report: Developing Opportunities within Inseego, Cato, FleetCor Technologies, Zogenix, Verisk Analytics, and XPO Logistics Future Expectations, Projections Moving into 2018 GlobeNewswire
Feb-27-18 08:00AM  Zogenix to Release Fourth Quarter and Full-Year 2017 Financial Results and Host Conference Call and Webcast on March 6 GlobeNewswire
Feb-23-18 11:52AM  Why Leerink Adjusted Upside Expectations For 3 Biotechs Benzinga
Feb-20-18 08:16PM  Zogenix Inc. (ZGNX) and Arena Pharmaceuticals, Inc. (ARNA) Helped This Healthcare-Focused Fund Earn Double-Digit Returns Insider Monkey
Feb-08-18 08:00AM  Zogenix to Participate in Leerink Partners 7th Annual Global Healthcare Conference GlobeNewswire
Feb-06-18 08:00AM  Zogenix Announces Receipt of FDA Breakthrough Therapy Designation for ZX008 in Dravet Syndrome GlobeNewswire +8.71%
Jan-31-18 04:05PM  Zogenix Completes Enrollment in Second ZX008 Phase 3 Clinical Trial in Dravet Syndrome GlobeNewswire
Zogenix, Inc., a pharmaceutical company, develops and commercializes therapies for the treatment of central nervous system disorders in the United States. Its lead product candidate is the ZX008, a low-dose fenfluramine, which is in Phase III clinical trials for the treatment of seizures associated with Dravet syndrome. The company was formerly known as SJ2 Therapeutics, Inc. and changed its name to Zogenix, Inc. in August 2006. Zogenix, Inc. was founded in 2006 and is headquartered in Emeryville, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MAST ERLE TDirectorNov 26Sale42.081,46861,7723,027Nov 26 09:33 PM
FARR STEPHEN JPresident and CEOOct 18Option Exercise28.0093726,23652,687Oct 19 05:20 PM
Farfel Gail MEVP/Chief Development OfficerOct 04Option Exercise13.966,96197,17614,104Oct 09 05:37 PM
Farfel Gail MEVP/Chief Development OfficerOct 04Sale43.236,961300,9287,143Oct 09 05:37 PM
MAST ERLE TDirectorOct 02Option Exercise26.811,46839,3604,495Oct 04 04:05 PM
Farfel Gail MEVP/Chief Development OfficerSep 04Option Exercise13.967,00097,72014,143Sep 05 04:14 PM
Farfel Gail MEVP/Chief Development OfficerSep 04Sale47.587,000333,0427,143Sep 05 04:14 PM
PERCEPTIVE ADVISORS LLC10% OwnerAug 10Buy52.00100,0005,200,0004,070,357Aug 14 09:00 AM
Farfel Gail MEVP/Chief Development OfficerAug 08Option Exercise13.967,00097,72014,143Aug 10 04:06 PM
Farfel Gail MEVP/Chief Development OfficerAug 08Sale52.627,000368,3137,143Aug 10 04:06 PM
Farfel Gail MEVP/Chief Development OfficerJun 12Option Exercise13.965,00069,80012,261Jun 13 08:57 PM
Farfel Gail MEVP/Chief Development OfficerJun 12Sale45.005,118230,3107,143Jun 13 08:57 PM
GARNER CAM LDirectorMay 16Option Exercise28.002186,104218May 17 04:12 PM
GARNER CAM LDirectorMay 16Sale39.902188,6980May 17 04:12 PM
HAWLEY ROGERDirectorMar 13Option Exercise16.1927,760449,424118,335Mar 14 04:15 PM
HAWLEY ROGERDirectorMar 13Sale44.6527,7601,239,43790,575Mar 14 04:15 PM
BOCK LOUIS CDirectorMar 12Option Exercise15.7524,716389,40024,716Mar 14 04:15 PM
HAWLEY ROGERDirectorMar 12Option Exercise28.007,240202,72097,815Mar 14 04:15 PM
HAWLEY ROGERDirectorMar 12Sale44.977,240325,54990,575Mar 14 04:15 PM
BOCK LOUIS CDirectorMar 12Sale44.8324,7161,108,1340Mar 14 04:15 PM
Galer Bradley S.EVP/Chief Medical OfficerDec 13Buy36.591,34649,2454,033Dec 15 04:26 PM
HAWLEY ROGERDirectorDec 11Option Exercise14.0963,203890,440135,316Dec 11 08:13 PM
HAWLEY ROGERDirectorDec 11Sale36.8463,2032,328,44390,575Dec 11 08:13 PM